Skip to main content

Find Clinical Trials

Home
Conditions
Resectable Glioblastoma

Clinical trial condition

Resectable Glioblastoma

Explore clinical trials studying Resectable Glioblastoma. Study availability and eligibility vary by location and protocol.

3 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Resectable Glioblastoma trial results

Recruiting

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

NCT07089641

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +12 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

NCT07301268

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +17 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

NCT06090903

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details